Literature DB >> 20519554

Organic anion transporter 6 (Slc22a20) specificity and Sertoli cell-specific expression provide new insight on potential endogenous roles.

Gloriane W Schnabolk1, Bhawna Gupta, Aditi Mulgaonkar, Mrugaya Kulkarni, Douglas H Sweet.   

Abstract

Organic anion transporter 6 (Oat6; Slc22a20), a member of the OAT family, was demonstrated previously to mediate the transport of organic anions (Am J Physiol Renal Physiol 291:F314-F321, 2006). In the present study, we sought to further delineate the function of murine Oat6 (mOat6) by analyzing the effect of select organic anions on mOat6-mediated transport by using a Chinese hamster ovary (CHO) cell line stably expressing mOat6 (CHO-mOat6). When examined, kinetic analysis demonstrated that the mechanism of inhibition of mOat6 and mOat3 was competitive. Homovanillic acid, 5-hydroxyindole acetic acid, 2,4-dihydroxyphenylacetate, hippurate, and dehydroepiandrosterone sulfate (DHEAS) each significantly reduced mOat6 activity with inhibitory constant (K(i)) values of 3.0 +/- 0.5, 48.9 +/- 10.3, 61.4 +/- 7.1, 59.9 +/- 4.9, and 38.8 +/- 3.1 microM, respectively. Comparison to K(i) values determined for mOat3 (67.8 +/- 7.2, 134.5 +/- 27.0, 346.7 +/- 97.9, 79.3 +/- 4.0, and 3.8 +/- 1.1 microM, respectively) revealed that there are significant differences in compound affinity between each transporter. Fluoroquinolone antimicrobials and reduced folates were without effect on mOat6-mediated uptake. Investigation of testicular cell type-specific expression of mOat6 by laser capture microdissection and quantitative polymerase chain reaction revealed significant mRNA expression in Sertoli cells, but not in Leydig cells or spermatids. Overall, these data should aid further refinements to the interpretation and modeling of the in vivo disposition of OAT substrates. Specifically, expression in Sertoli cells suggests Oat6 may be an important determinant of blood-testis barrier function, with Oat6-mediated transport of estrone sulfate and DHEAS possibly representing a critical step in the maintenance of testicular steroidogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519554      PMCID: PMC2939676          DOI: 10.1124/jpet.110.168765

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  35 in total

Review 1.  An oncological view on the blood-testis barrier.

Authors:  Joost Bart; Harry J M Groen; Winette T A van der Graaf; Harry Hollema; N Harry Hendrikse; Willem Vaalburg; Dirk T Sleijfer; Elisabeth G E de Vries
Journal:  Lancet Oncol       Date:  2002-06       Impact factor: 41.316

Review 2.  Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology.

Authors:  Adam L VanWert; Michael R Gionfriddo; Douglas H Sweet
Journal:  Biopharm Drug Dispos       Date:  2010-01       Impact factor: 1.627

Review 3.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

4.  Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice.

Authors:  Douglas H Sweet; David S Miller; John B Pritchard; Yuko Fujiwara; David R Beier; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

5.  Molecular identification of a renal urate anion exchanger that regulates blood urate levels.

Authors:  Atsushi Enomoto; Hiroaki Kimura; Arthit Chairoungdua; Yasuhiro Shigeta; Promsuk Jutabha; Seok Ho Cha; Makoto Hosoyamada; Michio Takeda; Takashi Sekine; Takashi Igarashi; Hirotaka Matsuo; Yuichi Kikuchi; Takashi Oda; Kimiyoshi Ichida; Tatsuo Hosoya; Kaoru Shimokata; Toshimitsu Niwa; Yoshikatsu Kanai; Hitoshi Endou
Journal:  Nature       Date:  2002-04-14       Impact factor: 49.962

Review 6.  A regulatory viewpoint on transporter-based drug interactions.

Authors:  L Zhang; Y D Zhang; J M Strong; K S Reynolds; S-M Huang
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

7.  Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin.

Authors:  Adam L Vanwert; Chutima Srimaroeng; Douglas H Sweet
Journal:  Mol Pharmacol       Date:  2008-04-01       Impact factor: 4.436

8.  Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination.

Authors:  David M Truong; Gregory Kaler; Akash Khandelwal; Peter W Swaan; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

9.  Impaired clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice: a gender specific impact of reduced folates.

Authors:  Adam L VanWert; Douglas H Sweet
Journal:  Pharm Res       Date:  2007-07-28       Impact factor: 4.200

10.  Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa.

Authors:  Julio C Monte; Megha A Nagle; Satish A Eraly; Sanjay K Nigam
Journal:  Biochem Biophys Res Commun       Date:  2004-10-15       Impact factor: 3.575

View more
  12 in total

Review 1.  The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.

Authors:  Sanjay K Nigam
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-01-06       Impact factor: 13.820

Review 2.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 3.  Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease.

Authors:  Li Wang; Douglas H Sweet
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

Review 4.  The blood-testis and blood-epididymis barriers are more than just their tight junctions.

Authors:  Payal Mital; Barry T Hinton; Jannette M Dufour
Journal:  Biol Reprod       Date:  2011-01-05       Impact factor: 4.285

Review 5.  The blood-testis barrier and its implications for male contraception.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Pharmacol Rev       Date:  2011-10-28       Impact factor: 25.468

6.  Shared Ligands Between Organic Anion Transporters (OAT1 and OAT6) and Odorant Receptors.

Authors:  Wei Wu; Kevin T Bush; Henry C Liu; Christopher Zhu; Ruben Abagyan; Sanjay K Nigam
Journal:  Drug Metab Dispos       Date:  2015-09-10       Impact factor: 3.922

Review 7.  Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis.

Authors:  Wei Wu; Ankur V Dnyanmote; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2011-02-11       Impact factor: 4.436

8.  Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier.

Authors:  Raymond K Hau; Robert R Klein; Stephen H Wright; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2022-03-20       Impact factor: 3.579

9.  Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11).

Authors:  Li Wang; Douglas H Sweet
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-21       Impact factor: 2.629

10.  Active Hydrophilic Components of the Medicinal Herb Salvia miltiorrhiza (Danshen) Potently Inhibit Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8).

Authors:  Li Wang; Douglas H Sweet
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.